foxo4 dri peptide senolytic study

foxo4 dri peptide senolytic study The disordered p53 transactivation domain is the target of and the compound FOXO4-DRI Targeted Apoptosis of Senescent Cells

Name: foxo4 dri peptide senolytic study The disordered p53 transactivation domain is the target of and the compound FOXO4-DRI Targeted Apoptosis of Senescent Cells
Brand: astonvaughan.co.uk
SKU: 94511200200
Price: 22.90 USD
Availability: InStock
Rating: 4.724500000000001 (27 reviews)

Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and Aging PMC FOXO4 DRI alleviates age related testosterone secretion insufficiency by targeting senescent Leydig cells in aged mice Aging Molecular modelling of the FOXO4 TP53 interaction to design senolytic peptides for the elimination of senescent cancer cells ScienceDirect FOXO4 DRI Vial 10mg Stemcode Peptides

SKU: 94511200200 · From astonvaughan.co.uk

4.7

USD22.90 USD42.90

Pay in 4 interest-free payments of $5.72 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Jul 29 - Aug 3

Description

Learn more Location: Jakarta PT Rodamas is a holding group of companies with various business sectors, and affiliate with other parties to build a wider business network